Category: ambulatory cardiac monitors

  • Boston Scientific to Acquire Preventice for ~$1.2B

    Shots: Boston Scientific to acquire Preventice for ~$1.2B including $925M as up front, up to an additional $300M as commercial milestones. However, Boston Scientific has built up a 22% stake in Preventice, which is expected to lower up front to $720M upfront & $230 million in milestone respectively The acquisition is expected to be close […]